Stanton保健公司以言论自由和获得医疗信息的机会为由,对拒绝使用堕胎药丸倒置广告牌的Lamar广告提起诉讼。 Stanton Healthcare sues Lamar Advertising over refusal to run abortion pill reversal billboards, citing free speech and access to medical information.

一家非营利诊所(Stanton Health Careuration)正在挑战拉马尔广告拒绝使用宣传堕胎药丸逆转的广告牌(APR), Stanton Healthcare, a nonprofit clinic, is challenging Lamar Advertising’s refusal to run billboards promoting abortion pill reversal (APR), a progesterone-based protocol aimed at reversing the first abortion pill. 美国法律与司法中心 (ACLJ) 认为拒绝是观点歧视,并指出没有FDA规定禁止APR广告,据报道该程序已经帮助超过8,000名妇女安全地继续怀孕. The American Center for Law and Justice (ACLJ) argues the refusal constitutes viewpoint discrimination, noting no FDA regulations prohibit APR advertising and that the procedure has reportedly helped over 8,000 women continue pregnancies safely. Stanton强调APR得到医疗支持和同情,敦促Lamar允许开展这项运动,以确保妇女获得真实的、以科学为基础的医疗保健信息。 Stanton emphasizes APR is medically supported and compassionate, urging Lamar to allow the campaign to ensure women access truthful, science-based healthcare information. 这一决定引发了关于言论自由、公司对医疗信息的控制以及获得生殖健康选择权的辩论。 The decision has ignited debate over free speech, corporate control of medical messaging, and access to reproductive health options.